Analysts on the Street continue to back top drugmakers Dr Reddy's Laboratories and Cipla even as investors rushed to cash out profits off the two scrips after their bull run in the past two years.

Dr. Reddy’s Laboratories has recently become the first Indian company to launch checkpoint inhibitor Zytorvi (toripalimab) in collaboration with Shanghai Junshi Biosciences. Zytorvi is a ...

Traders may consider this as an accumulation opportunity with a stop-loss below Rs 3,300. Dr Reddy's Laboratories is currently trading near its ascending trendline support at Rs 1,200, which ...

Dr. Reddy’s Laboratories has launched Toripalimab, a New Biological Entity (NBE) in the domestic market. “The launch of Toripalimab is a significant milestone for patients diagnosed with ...

New Delhi, Nov 28 (PTI) Dr Reddy's Laboratories on Thursday said it has launched Toripalimab, a drug for the treatment of recurrent or metastatic nasopharyngeal carcinoma in India. Nasopharyngeal ...

"He has been released," Ashok Reddy, his counsel, told reporters at the Chanchalguda prison. Immediately after the release, the actor was driven to his residence and he was seen hugging his family.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active ...

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) said that it has launched Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma.

Dr. Reddy’s (RDY) Laboratories and Senores Pharmaceuticals announced the launch of Ivermectin Tablets USP, 3 mg, which is bioequivalent and therapeutically equivalent to STROMECTOL Tablets of ...

Dr. Reddy’s Laboratories Ltd. on Thursday announced the launch of Toripalimab in India. According to company’s statement, Toripalimab is a New Biological Entity (NBE). “It is the only immuno ...

HYDERABAD, India, November 26, 2024--(BUSINESS WIRE)--Dr. Reddy's Laboratories, Inc. and Senores Pharmaceuticals, Inc. today announced the launch of Ivermectin Tablets USP, 3 mg, which is ...

The Subject Expert Committee (SEC) of the central drug regulatory authority has recommended grant of approval to Dr Reddy's Laboratory for import and market new drug Tegoprazan in the country for use ...